Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
NCT03906318 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-09-30
Summary
Expanded Access Use of Itacitinib to Treat a Single Patient With Aplastic Anemia
Conditions
- Aplastic Anemia
Interventions
- DRUG
-
Iticitinib
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Lisa Forbes Satter, MD · Baylor College of Medicine - Texas Children's Hospital
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A First Human Study of a Ferroportin Antibody
NCT01330953 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease
NCT01846689 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia
NCT03399084 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002071 ·Status: COMPLETED ·Phase: NA
-
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
NCT07010237 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia
NCT01464164 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®
NCT02453334 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
NCT00367991 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia
NCT02964936 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia
NCT00002042 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Sustained Erythropoietin Therapy
NCT00542568 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia
NCT01716923 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002072 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
NCT02612558 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin
NCT01363934 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia
NCT01114217 ·Status: COMPLETED ·Phase: PHASE3
-
Erythropoietin Alfa in Elderly Subjects With Unexplained Anemia
NCT00954486 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients
NCT00204334 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID
NCT02999984 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera
NCT03287245 ·Status: TERMINATED ·Phase: PHASE2
-
The Benefits of a Preoperative Anemia Management Program
NCT01888003 ·Status: TERMINATED ·Phase: NA
-
Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome
NCT01546337 ·Status: TERMINATED
-
Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers
NCT00687518 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
NCT02900183 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07075484 ·Status: COMPLETED ·Phase: PHASE1